ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,224Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 890

$1.05M Total Retail Price of All Prescriptions

Rank: 46 out of 890

739 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 739 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 739 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 16,081 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METOPROLOL TARTRATE 613 512 1 15
LEVOTHYROXINE SODIUM 542 493 2 2
LISINOPRIL 528 408 3 4
METFORMIN HCL 504 422 4 6
FUROSEMIDE 458 413 5 7
GABAPENTIN 441 383 6 12
AMLODIPINE BESYLATE 438 360 7 1
SIMVASTATIN 395 345 8 5
WARFARIN SODIUM 374 368 9 24
TRAMADOL HCL 372 332 10 16
LOVASTATIN 354 310 11 46
POTASSIUM CHLORIDE 354 314 11 11
CITALOPRAM HBR 318 283 13 20
HYDROCHLOROTHIAZIDE 312 256 14 9
NAMENDA 307 306 15 36
OMEPRAZOLE 276 223 16 8
LOSARTAN POTASSIUM 265 255 17 29
DONEPEZIL HCL 224 224 18 30
CARVEDILOL 206 185 19 22
CLONIDINE HCL 202 157 20 35
NEXIUM 194 156 21 14
AMITRIPTYLINE HCL 192 156 R 22 43
HYDROCODONE-ACETAMINOPHEN 183 131 S3 23 3
MEGESTROL ACETATE 179 167 R 24 92
QUETIAPINE FUMARATE 170 134 25 73
ENALAPRIL MALEATE 167 155 26 56
OXYBUTYNIN CHLORIDE 165 141 27 139
CAPTOPRIL 159 132 28 254
CLOPIDOGREL 147 126 29 28
ATENOLOL 146 120 30 23
DIOVAN 146 129 30 33
ALLOPURINOL 144 103 32 31
PANTOPRAZOLE SODIUM 142 108 33 34
ALENDRONATE SODIUM 141 124 34 38
PREDNISONE 140 131 35 47
GLIPIZIDE 131 87 36 62
HYDRALAZINE HCL 131 108 36 100
FLUTICASONE PROPIONATE 128 99 38 39
ZOLPIDEM TARTRATE 122 110 39 19
ATORVASTATIN CALCIUM 121 93 40 13
ISOSORBIDE MONONITRATE ER 120 116 41 60
TRIAMTERENE-HCTZ 120 105 41 61
VERAPAMIL ER 119 95 43 87
GEMFIBROZIL 119 95 43 103
MELOXICAM 114 78 45 18
TAMSULOSIN HCL 111 98 46 32
AZITHROMYCIN 107 93 47 37
ALPRAZOLAM 106 99 48 95
LANTUS 104 91 49 50
PRAVASTATIN SODIUM 104 82 49 10
RISPERIDONE 103 103 51 78
MIRTAZAPINE 97 87 52 82
CIPROFLOXACIN HCL 94 83 53 58
PLAVIX 94 79 53 42
CRESTOR 92 74 55 25
DIVALPROEX SODIUM 89 57 56 126
ZOSTAVAX 88 74 57 233
OLANZAPINE 86 76 58 145
CARBIDOPA-LEVODOPA 84 59 59 136
EXELON 83 71 60 113
GLIMEPIRIDE 78 62 61 27
ADVAIR DISKUS 77 72 62 52
CYMBALTA 76 70 63 45
KLOR-CON M10 76 57 63 165
DIGOXIN 75 75 65 65
PRAMIPEXOLE DIHYDROCHLORIDE 70 55 66 175
NOVOLOG 70 62 66 178
METOPROLOL SUCCINATE 68 60 68 17
BENAZEPRIL HCL 68 50 68 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 52 68 76
SPIRONOLACTONE 68 56 68 85
BENICAR 67 57 72 180
SEROQUEL 66 56 73 167
DETROL LA 63 60 74 164
PAROXETINE HCL 62 58 75 68
NOVOLIN R 61 48 76 153
SPIRIVA 60 59 77 66
SINGULAIR 59 38 78 79
METHYLPREDNISOLONE 58 46 79 109
INSULIN SYRINGE 56 41 80 99
LOSARTAN-HYDROCHLOROTHIAZIDE 53 53 81 57
CLOZAPINE 52 26 82 279
DOXAZOSIN MESYLATE 51 40 83 70
DIAZEPAM 51 45 83 278
CARBAMAZEPINE 50 34 85 238
NOVOLOG MIX 70-30 50 31 85 313
LORAZEPAM 50 47 85 195
SERTRALINE HCL 50 41 85 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.